Lopinavir
Products in Health Canada’s databases that list Lopinavir as a medicinal or active ingredient, under this spelling. The same substance can be listed under another name (a salt, a common name), which has its own page.
- Drug products
- 4
- 3 authorized now
- Natural health products
- 0
- 0 active licences
- Notices of Compliance
- 21
- Products in all
- 4
Drug products
Authorized products first.
| Name | DIN | Status | Holder | Status since |
|---|---|---|---|---|
| KALETRA (400 MG) | 02243644 | Marketed | AbbVie Corporation | |
| KALETRA (200 MG) | 02285533 | Marketed | AbbVie Corporation | |
| KALETRA (100 MG) | 02312301 | Marketed | AbbVie Corporation | |
| KALETRA (133.3 MG) | 02243643 | Cancelled Post Market | AbbVie Corporation |
Notices of Compliance
Approvals of drug submissions that list it, newest first.
- KALETRAJuly 14, 2026 · NOC 37918
- KALETRAFebruary 13, 2026 · NOC 36905
- KALETRAMarch 19, 2025 · NOC 35037
- KALETRAJuly 9, 2021 · NOC 26242
- KALETRAJanuary 7, 2021 · NOC 24948
- KALETRADecember 11, 2020 · NOC 24788
- KALETRAMay 2, 2018 · NOC 20818
- KALETRADecember 15, 2017 · NOC 20166
- KALETRAOctober 6, 2017 · NOC 19891
- KALETRAJuly 12, 2016 · NOC 18287
- KALETRANovember 17, 2015 · NOC 17539
- KALETRANovember 1, 2012 · NOC 13806
- KALETRAAugust 27, 2010 · NOC 11696
- KALETRAJune 4, 2010 · NOC 11482
- KALETRAJuly 15, 2009 · NOC 10375
- KALETRAJune 10, 2008 · NOC 9603
- KALETRAJuly 9, 2007 · NOC 8897
- KALETRASeptember 6, 2006 · NOC 8245
- KALETRAOctober 12, 2005 · NOC 7545
- KALETRAMarch 26, 2004 · NOC 275
- KALETRAMarch 9, 2001 · NOC 2380